Selbyville, Delaware, Nov. 23, 2022 (GLOBE NEWSWIRE) --
Chronic venous occlusions treatment market value is anticipated to exceed USD 9.5 billion by 2030, according to a new research report by Global Market Insights Inc.
The effectiveness of chronic venous insufficiency treatment has greatly improved over time with technological innovations, which is a major factor influencing industry expansion. The development of compression devices and radiofrequency ablation for the identification and treatment of varicose veins has significantly impacted the market worldwide. Additionally, thermal ablation has revolutionized venous therapies for treating superficial truncal reflux.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/5398
Increasing availability of advanced medical devices to boost product sales
Chronic venous occlusions treatment market from devices segment is set to reach over USD 4.5 billion by 2030. The product demand is projected to rise in response to the growing need for advanced therapeutic and medical devices to treat chronic venous occlusions. This is attributable to multiple benefits that are offered by compression devices, endovenous ablation, sclerotherapy, and other devices. The high prevalence of patients with leg ulcers, varicose veins, chronic venous illnesses, stasis ulcers, and deep vein thrombosis, among other conditions, has led to a significant increase in the adoption of these devices.
High hospitalization rates to fuel varicose veins segment expansion
Chronic venous occlusions treatment market from varicose veins segment is projected to increase at over 5% CAGR through 2030 owing to a widening patient base and an upsurge in hospitalizations among adults suffering from varicose veins resulting from weak or damaged leg valves. The aging population, multiple pregnancies, obesity, and other factors are affecting morbidities and are likely to amplify segment size.
Browse key industry insights spread across 271 pages with 339 market data tables & 16 figures & charts from the report, “Chronic Venous Occlusions Treatment Market Analysis by Product (Devices {Compression Devices, Endogenous Ablation [Laser Ablation, Radiofrequency Ablation], Sclerotherapy, Vein-stripping}, Drugs {Analgesics, Antibiotics, Anticoagulants}), Application (Varicose Veins, Venous Stasis Ulcers, Edema, Deep Vein Thrombosis), End-Use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/chronic-venous-occlusions-treatment-market
Growing acceptance of advanced technological devices at hospitals to expand segmental share
Chronic venous occlusions treatment market from hospitals segment was valued at over USD 3.5 billion in 2021. The rapid adoption of technologically improved venous occlusion devices, coupled with the availability of minimally invasive treatment alternatives for numerous lower extremity disorders to aid a large client base, is mainly responsible for segment growth. Rising patient admissions with chronic venous diseases, improved access to better care and diagnostics, and the presence of experienced healthcare personnel will increase patient visits to hospitals, escalating the overall segment revenues.
Increasing hospitalization rate to amplify Europe’s revenue share
Europe chronic venous occlusions treatment market is expected to be worth over USD 2.5 billion by 2030 driven by the rising hospitalization rate brought on by the high frequency of venous leg ulcers, lower extremity disorders, chronic venous insufficiency, and supporting healthcare policies. Additionally, several screening programs and awareness campaigns implemented by the regulatory authorities are primed to complement business expansion.
Request for customization of this research report @ https://www.gminsights.com/roc/5398
Product innovations to define the market outlook
Stryker Corporation, Sanofi, Medtronic plc, Sigvaris AG, Pfizer Inc., Medi GmbH & Co. KG, Tactile Medical, Julius Zorn GmbH, Bristol Myers Squibb, Smith & Nephew PLC, Viatris Inc., Boston Scientific Corporation, Merz Pharma, Lumenis Ltd., Candela, Bayer AG, Sciton, Inc, Fotona, ConvaTec Inc., Leucadia Pharmaceuticals (Hikma), 3M Company, and Venclose, Inc. (Becton Dickinson and Company) and others are some major medical and healthcare technology companies operating in the market.
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
